The bovine diagnostics market is projected to grow significantly, reaching a value of US$ 2,011.15 million by 2030, up from US$ 1,155.59 million in 2022. This growth represents an estimated compound annual growth rate (CAGR) of 7.2% from 2022 to 2030.
Ongoing research and development initiatives are enabling veterinary diagnostics firms to introduce a variety of innovative diagnostic tools that yield quick results. Furthermore, increased awareness among users, driven by government educational and outreach programs, has motivated these companies to develop advanced diagnostic solutions. Below are some notable recent product introductions in the bovine diagnostics market.
• In June 2023, Zoetis, Inc. unveiled Vetscan Mastigram+, an on-farm diagnostic tool for mastitis that delivers results eight hours prior to the next milking. This product employs a flow dipstick test to identify Gram-positive mastitis in cattle, achieving 99% sensitivity and 100% specificity in detecting Gram-positive pathogens in cow milk, while also distinguishing between Gram-positive and Gram-negative bacteria.
• Also in June 2023, Neogen Corporation introduced Igenity^ BeefXDairy, a DNA testing solution tailored for beef-on-dairy cattle. This test provides producers with valuable insights into traits such as carcass quality, average daily gain, and the Igenity Terminal Index. Additionally, it offers buyers breed composition data to enhance cattle health management and optimize product yield.
• In August 2023, Biotangents, a biotech firm based in Scotland, launched its advanced molecular diagnostic assay?AmpliSpec LAB Mastitis. The company asserts that this assay boasts a high level of sophistication, with 93% sensitivity and 95% specificity for detecting mastitis pathogens in dairy cows.
The rise in foot and mouth disease occurrences is anticipated to drive the growth of the bovine diagnostics market.
Foot and mouth disease (FMD) is a highly contagious viral infection that poses a significant economic threat to livestock, affecting cattle, swine, sheep, goats, and other cloven-hoofed animals. As a transboundary animal disease (TAD), FMD disrupts the trade of livestock and animal products on both regional and global scales. The World Organization for Animal Health estimates that 77% of the global livestock population is affected by this disease, particularly in regions such as Africa, the Middle East, and Asia, with some cases reported in South America. Countries with lower income levels bear approximately 75% of the costs associated with FMD prevention and control, with Africa and Eurasia accounting for about 50% of these expenses. There are seven strains of the Aphthovirus (A, O, C, SAT1, SAT2, SAT3, and Asia1) that are endemic in various regions worldwide. Effective prevention of FMD relies on early detection, robust surveillance systems, and other strategic measures, with each strain necessitating a specific vaccine to ensure immunity in vaccinated animals.
Common diagnostic methods for FMD include infection-associated antigen (VIA) tests, complement fixation (CF), ELISA, and PCR tests, which are used to identify FMD viral antigens, isolate the virus, and perform neutralization tests. IDEXX provides the IDEXX FMD 3 ABC Ab Test Kit, an enzyme immunoassay designed to detect antibodies against FMDV in serum or plasma samples derived from bovines.
Consequently, these factors are expected to significantly contribute to the growth of the bovine diagnostics market, particularly in the segment focused on foot and mouth disease.
Market Segmentation Overview:
The "Global Bovine Diagnostics Market" is categorized based on product type, disease classification, and end-user demographics.
In terms of product type, the bovine diagnostics market is divided into immunoassay kits, PCR kits, hemagglutination inhibition (HI) assays, and other diagnostic tools. The immunoassay kits segment held the largest market share in 2022 and is projected to experience the highest CAGR from 2022 to 2030.
Regarding disease classification, the market is segmented into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and other diseases. The bovine mastitis segment dominated the market in 2022 and is expected to maintain a strong growth trajectory through 2030.
From the perspective of end users, the bovine diagnostics market is classified into veterinary hospitals, veterinary clinics, and other facilities. The veterinary hospitals segment accounted for the largest market share in 2022 and is anticipated to show the highest growth rate during the forecast period.
Key players in the bovine diagnostics market include Idexx Laboratories Inc, PBD Biotech Ltd, Thermo Fisher Scientific Inc, Innovative Diagnostics SAS, Neogen Corp, Enfer Labs, bioMerieux SA, Ring Biotechnology Co Ltd, Bionote Inc, and Shenzhen Bioeasy Biotechnology Co Ltd.
Important primary and secondary sources utilized in the preparation of the report on the bovine diagnostics market include organizations such as the American Association for Thoracic Surgery (AATS), the Centers for Disease Control and Prevention (CDC), the National Institute for Health and Care Excellence (NICE), the Organisation for Economic Co-operation and Development (OECD), and the Spanish National Health System (SNS).